Target intelligence / Profile preview

ZKSCAN2 divergent transcript (ZKSCAN2-DT)

Target
ZKSCAN2-DT
Molecular classification
Other (Long non-coding RNA)
01

Overview

ZKSCAN2 divergent transcript (ZKSCAN2-DT) is an annotated long non-coding RNA located near the ZKSCAN2 gene, typically transcribed from the opposite strand in a head-to-head (divergent) configuration. Such divergent lncRNAs are often co-expressed with their protein-coding neighbors and are thought to be involved in the regulation of gene expression, particularly affecting transcriptional regulators like ZKSCAN2[1][2][4]. These transcripts do not encode proteins and are not established as direct therapeutic targets, biomarkers, or drug targets. ZKSCAN2-DT is not a receptor, enzyme, or other classical “drug target” molecule. There is no evidence of direct disease association or roles in specific pathological processes for ZKSCAN2-DT itself, although the neighboring ZKSCAN2 gene (a zinc finger and SCAN domain-containing transcription factor) is involved in gene regulation and cancer biology[3].

Other names
CTD-2547G23.4ZKSCAN2-DT
02

Biological functions

Regulation of transcription (likely via modulation of its neighboring ZKSCAN2 gene)Potential involvement in gene expression regulation

Beyond the preview

Go deeper on ZKSCAN2 divergent transcript (ZKSCAN2-DT).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ZKSCAN2 divergent transcript (ZKSCAN2-DT).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call